| RS2494484801 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS2494486169 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Wilms tumor 1 |
| RS2494488708 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2494494292 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494497146 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494498245 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494498363 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494500513 |
OAT
|
Health Risk |
Likely pathogenic |
Ornithine aminotransferase deficiency, Hyperornithinemia |
| RS2494500603 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494501124 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494502096 |
OAT
|
Health Risk |
Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494503071 |
OAT
|
Health Risk |
Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494503596 |
SBF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494506149 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494507745 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494507974 |
HPS5
|
Health Risk |
Likely pathogenic |
— |
| RS2494512458 |
PAX5
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2494512979 |
PAX5
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2494513770 |
SBF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494516617 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494516804 |
NT5C2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 45, Hereditary spastic paraplegia 45 |
| RS2494516860 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494516881 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494522736 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494523338 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494523429 |
OAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494525612 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494525637 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS2494525720 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494526165 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494528886 |
ACTA2
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS2494532805 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494533554 |
PSAP
|
Health Risk |
Likely pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494535401 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494541474 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Sphingolipid activator protein 1 deficiency, Neuromuscular disease |
| RS2494541533 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Gaucher disease due to saposin C deficiency |
| RS2494541782 |
PSAP
|
Health Risk |
Pathogenic |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS2494556210 |
PAX5
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2494585590 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494594074 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS2494599240 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494600372 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2494602199 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2494605090 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2494605326 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2494611829 |
LDHA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS2494620013 |
SBF2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494629397 |
CARS1
|
Health Risk |
Pathogenic |
Microcephaly, developmental delay |
| RS2494631340 |
EPS8L2
|
Health Risk |
Pathogenic |
— |
| RS2494642835 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2494643428 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2494644051 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2494644442 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2494644980 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2494645313 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2494678682 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494681209 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494683377 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494686109 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494703615 |
PDHX
|
Health Risk |
Likely pathogenic |
— |
| RS2494706450 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494707071 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494708669 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494708862 |
PDHX
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS2494716427 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2494716906 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS2494721611 |
PDHX
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS2494724434 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2494726862 |
CCDC34
|
Health Risk |
Pathogenic |
Spermatogenic failure 76, Spermatogenic failure 76 |
| RS2494728791 |
PDHX
|
Health Risk |
Pathogenic |
— |
| RS2494732058 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS2494732361 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS2494732943 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS2494735922 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2494736104 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494736729 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2494739987 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2494744424 |
PDHX
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS2494749848 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494750272 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494750358 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494750488 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494750713 |
RAG1
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Histiocytic medullary reticulosis |
| RS2494751448 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494751587 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494751635 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494752082 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494752085 |
RAG1
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494752351 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Severe combined immunodeficiency |
| RS2494752916 |
RAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Severe combined immunodeficiency |
| RS2494753295 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494753892 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494754161 |
RAG1
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2494754517 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494754724 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494754990 |
RAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to partial RAG1 deficiency, Histiocytic medullary reticulosis |
| RS2494755383 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS2494756760 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494757178 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to partial RAG1 deficiency, Combined immunodeficiency due to partial RAG1 deficiency |
| RS2494757326 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |